Cognitio

In this week’s ARCS Weekly News Wrap, Tim Boyle recaps a major week for Australia’s life sciences sector during National Clinical Trials Week. The episode covers key developments across pharma, medtech, biotech, policy and investment, along with insights from ARCS’ activities in Melbourne, including the launch of the Clinical Workforce White Paper, the new ARCS and MAPA strategic alliance, and sec...

In this episode of the Cognitio Podcast, host Tim Boyle explores one of the most critical equity challenges in Australian healthcare: ensuring safe, effective, culturally informed use of medicines for First Nations peoples. Tim is joined by four respected leaders in medicine safety: Karen Battat (AstraZeneca), Vinham Mehta (Novartis), Marcela Bade (former TGA pharmacovigilance inspector) and Matt...

This week’s wrap brings you the biggest developments across Australia’s life sciences sector — all in one quick, engaging update. We cover major pharma moves, medtech breakthroughs, biotech investment momentum, regulatory updates, and the latest people movements shaping the industry. From gene therapy and GLP-1 dealmaking to AI in radiology and standout Australian clinical results, this episode hi...

What is Intellectual Property? A Practical Guide for Australia’s Life Sciences Sector In this episode of Cognitio , Tim Boyle takes listeners on a clear and engaging tour of the intellectual property landscape, guided by three specialists from Spruson and Ferguson Lawyers. IP sits at the core of innovation and commercialisation in the life sciences, yet it is often misunderstood or overlooked unti...

In this week’s episode, Anna Megalakakis steps behind the mic to bring you a fast-paced and insightful roundup of the biggest developments across Australia’s life sciences sector. From blockbuster pharma shifts and cutting-edge medtech launches to biotech investment momentum and major leadership movements, this episode unpacks what matters — and why. Anna also shares the latest from ARCS, includin...

In this episode of The Cognitio Podcast , ARCS Australia CEO Tim Boyle introduces highlights from a thought-provoking ARCS Interest Area webinar, Automating Life Science Workflows through AI , presented by Dr Rishi Verma , CEO and Founder of Stethy AI . Dr Verma, a physician and engineer, takes listeners inside the fast-evolving world of artificial intelligence in the life sciences. Drawing direct...

This week’s episode dives into the biggest stories shaping Australia’s life sciences landscape — from global leadership milestones to biotech breakthroughs and policy reform. We celebrate Professor Tony Lawler’s appointment as Global Chair of the International Coalition of Medicines Regulatory Authorities (ICMRA) , marking Australia’s growing influence in global regulatory science. In pharma, Take...

Next Generation Nuclear Medicine: Powering the Future of Precision Health In this episode of ARCS Cognitio , ARCS Australia CEO Tim Boyle leads a compelling conversation on the rapidly evolving world of next-generation nuclear medicines — where physics meets biology to transform how we diagnose and treat disease. Joined by a panel of industry leaders — Christian Behrenbruch (Telix Pharmaceuticals)...

ARCS Weekly News Wrap – Week Ending 25 October 2025 This week’s episode covers a powerhouse mix of policy shifts, scientific breakthroughs, and leadership changes shaping Australia’s life sciences landscape. Join Tim Boyle , CEO of ARCS Australia, as he unpacks: Pharma: Landmark PBS listings, proactive pharmacovigilance, and new rare disease breakthroughs Medtech: HTA review tensions, hospital fun...

In this week’s ARCS Weekly News Wrap, Tim Boyle returns from Adelaide after the KCA Conference to bring you the top stories shaping Australia’s life sciences sector. This episode covers: • Pharma: FDA approval for MSD’s subcutaneous Keytruda, Eli Lilly’s oral obesity drug heading to the TGA, and J&J’s Stelara patent challenge. • Medtech: AI-assisted diagnostics at Macquarie University and Opta...

This week’s ARCS Weekly News Wrap dives into the biggest stories shaping pharma, medtech, biotech, and the workforce behind them. From the MAPA-MAPS Summit and student careers fairs to global debates over paracetamol, robotic surgery innovations, and major biotech funding deals — we break it all down and explain what it means for you. Highlights include: The rise of medical affairs and ARCS’ caree...

In this episode of the Cognitio Podcast, Goce Bogeski FMPP shares his reflections on the often-overlooked similarities between pharmaceuticals and medical devices. Drawing on years of experience across both fields, he explains how market access processes converge, where inefficiencies exist, and why evidence plays such a critical role in reimbursement decisions. From the challenges of the prosthes...

Weekly News Wrap – 19 September 2025 This week’s ARCS Weekly News Wrap is packed with sector-shaping stories across pharma, medtech, biotech, and leadership. Tim Boyle recaps a milestone few days for ARCS, including a sold-out Leadership & Communications Symposium and a record turnout at our networking night with AMWA. In pharma, Australian science takes the global stage with Pfizer’s breast c...

Australia’s R&D Tax Incentive is one of the most significant programs driving investment and innovation in the life sciences. But how does it really work in practice, and what do the latest transparency data tell us about the companies claiming it? In this episode of the ARCS Cognitio Podcast, host Tim Boyle brings you highlights from a recent ARCS webinar with experts from EY. Together they u...

This week’s ARCS Biopharma & Medtech Wrap dives into the biggest headlines shaping the life sciences sector – from pharma restructures and drug pricing debates to medtech innovation and Australian biotech success stories. We cover: Pharma: Novo Nordisk’s 9,000 job cuts, Lundbeck’s global exits, Takeda’s narcolepsy breakthrough, and the growing debate on PBS and international drug pricing. Medt...

In this episode of the ARCS Cognitio Podcast, we explore the regulatory framework for in vitro diagnostic (IVD) medical devices with international regulatory affairs expert Dr Adel Schneider . IVDs—from pregnancy tests to advanced blood screening assays—play a critical role in healthcare by providing the information that guides diagnosis and treatment. But how do regulators ensure these devices ar...

This week on the ARCS Weekly Life Sciences Wrap , we unpack the stories driving the future of medicine, policy, and innovation in Australia. From Canberra to the clinic, it’s been a week of breakthroughs, delays, and bold moves. Health Minister Mark Butler has finally announced the first steps toward reforming Australia’s Health Technology Assessment system — a long-awaited shift that could change...

How do you know if a new product can be marketed in Australia? The answer lies in the very first questions you ask. In this episode of the Cognitio podcast, ARCS Australia CEO Tim Boyle sits down with Dr Helena Dickinson, a regulatory affairs consultant with over 30 years of experience in medicines and medical devices. Together, they unpack the critical steps in classifying a product and determini...

This week in the ARCS Australia Weekly Medtech & Pharma Wrap we delve into the stories that are shaping our industry. From quantum blood testing and vaccination patches that are needle-free, through blockbuster drug wars, policy debates, and company culture – the picture is clear: innovation is racing, and access and capacity need to keep up. Watch the newest episode now and stay one step ahea...

In this episode of Cognitio , ARCS CEO Tim Boyle is joined by Professor Andrew Wilson, Co-Director of the Menzies Centre for Health Policy and Economics at the University of Sydney and Chair of the Implementation Advisory Group for HTA Reform. Drawing on his deep experience as former Chair of the PBAC and now a central figure in shaping reform, Professor Wilson reflects on the challenges of transl...

In this Cognitio episode, host Tim Boyle is joined by Adele Barnard to explore the fast-changing world of implantable medical device regulation in Australia. Drawing on Adele’s first-hand industry experience, the episode unpacks the TGA’s definition of medical devices, the full lifecycle from pre-approval to post-market surveillance, and the critical steps that sponsors and manufacturers must navi...

In this episode of Cognitio , ARCS Australia CEO Tim Boyle speaks with leadership and team performance coach Matt Brown about one of the defining capabilities of our time: resilience. Drawing on over 25 years of experience helping leaders and teams navigate disruption, Matt unpacks how to build resilience at both an individual and organisational level. From understanding the VUCA (Volatile, Uncert...

In this episode of the Cognitio Podcast , we sit down with Brenton Judge, Executive General Manager at Hendon Semiconductors, to explore the real-world challenges and considerations in outsourced manufacturing. With over three decades of experience in large-scale operations across Asia and Australia, Brenton shares frank insights into what makes—or breaks—a vendor relationship. We cover: Why early...

In this episode, ARCS CEO Tim Boyle speaks with Greg Taylor from the Copyright Agency about one of the most overlooked risks in the pharmaceutical and medtech sectors: copyright compliance. Greg unpacks what copyright means in an Australian context, how it applies to regulatory affairs, pharmacovigilance, and clinical research workflows, and why simply buying or accessing an article isn’t the same...

What does it take to create a future-proof framework for data sharing in clinical research? In this episode of Cognitio , Tim Boyle is joined by Dr Lisa Eckstein, Program Director of CT:IQ, to unpack a major national initiative reshaping how Australian researchers think about data access, consent, and governance. Lisa shares insights from her work with the Australian Research Data Commons (ARDC) o...